Cargando…

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity

BACKGROUND: This study measured longitudinal changes in dry eye disease (DED) symptoms and signs following lifitegrast therapy and assessed their relationship to tear osmolarity to test the hypothesis that a decline in tear osmolarity is a reliable leading indicator of subsequent improvement in DED...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pepose, Jay S, Qazi, Mujtaba A, Devries, Douglas K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445190/ https://www.ncbi.nlm.nih.gov/pubmed/30992657 http://dx.doi.org/10.2147/OPTH.S196593

Ejemplares similares

Tear osmolarity and dry eye symptoms in diabetics
por: Fuerst, Nicole, et al.
Publicado: (2014)

Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study
por: Greiner, Jack V., et al.
Publicado: (2023)

Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
por: Godin, Morgan R, et al.
Publicado: (2017)

Evaluation of tear osmolarity measured by I-Pen osmolarity system in patients with dry eye
por: Park, Jongyeop, et al.
Publicado: (2021)

Dry eye syndrome: developments and lifitegrast in perspective
por: Lollett, Ivonne V, et al.
Publicado: (2018)

Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease
por: Tashbayev, Bezhod, et al.
Publicado: (2020)

Tear Osmolarity in the Diagnosis of Systemic Dehydration and Dry Eye Disease
por: Bron, Anthony J., et al.
Publicado: (2021)

Short-term changes in tear osmolarity after instillation of different osmolarity eye drops in patients with dry eye
por: Kim, Woojin, et al.
Publicado: (2023)

Tear Film Osmolarity Measurement in Japanese Dry Eye Patients Using a Handheld Osmolarity System
por: Shimazaki, Jun, et al.
Publicado: (2020)

Tear film osmolarity and dry eye disease: a review of the literature
por: Potvin, Richard, et al.
Publicado: (2015)

The Effect of Lifitegrast on Refractive Accuracy and Symptoms in Dry Eye Patients Undergoing Cataract Surgery
por: Hovanesian, John, et al.
Publicado: (2020)

Lifitegrast: A novel drug for treatment of dry eye disease
por: Abidi, Afroz, et al.
Publicado: (2016)

Lifitegrast: a novel drug for patients with dry eye disease
por: Haber, Stacy L., et al.
Publicado: (2019)

Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome
por: Kook, Kyung Yun, et al.
Publicado: (2020)

Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease
por: Semba, Charles P, et al.
Publicado: (2016)

Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone
por: Lee, Ji Hwan, et al.
Publicado: (2014)

Diagnostic Performance of the Tear Meniscus Osmolarity Measurement for Dry Eye Disease in Rheumatoid Arthritis Patients
por: De La Parra-Colin, Paola, et al.
Publicado: (2023)

Reduction of Artificial Tears and Use of Adjunctive Dry Eye Therapies After Lifitegrast Treatment: Evidence from Clinical and Real-World Studies
por: Nichols, Kelly K, et al.
Publicado: (2022)

Computed tear film and osmolarity dynamics on an eye-shaped domain
por: Li, Longfei, et al.
Publicado: (2016)

The Significance of Inter-Eye Osmolarity Difference in Dry Eye Diagnostics
por: Nilsen, Christian, et al.
Publicado: (2023)

Analysis of basal and reflex human tear osmolarity in normal subjects: assessment of tear osmolarity
por: Abusharha, Ali A., et al.
Publicado: (2018)

Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease
por: Choi, Moonjung, et al.
Publicado: (2023)

The Effects of Hemodialysis on Tear Osmolarity
por: Taskapili, Muhittin, et al.
Publicado: (2015)

Estimating the Osmolarities of Tears During Evaporation Through the “Eyes” of the Corneal Nerves
por: Hirata, Harumitsu, et al.
Publicado: (2017)

Investigation of the repeatability of tear osmolarity using an I-PEN osmolarity device
por: Fagehi, Raied, et al.
Publicado: (2020)

A novel system, TearCare(®), for the treatment of the signs and symptoms of dry eye disease
por: Badawi, David
Publicado: (2018)

LIFITEGRAST 5% FOR DRY EYE DISEASE: COMBINED EFFICACY AND SAFETY FROM FIVE RANDOMIZED CONTROLLED TRIALS
por: Gonzalez, Agustin L, et al.
Publicado: (2019)

Effect of Pterygium Surgery on Tear Osmolarity
por: Türkyılmaz, Kemal, et al.
Publicado: (2013)

Comment on “The Effects of Hemodialysis on Tear Osmolarity”
por: Ayyildiz, Onder, et al.
Publicado: (2016)

Tear osmolarity after cataract surgery
por: Elksnis, Ēriks, et al.
Publicado: (2018)

PACAP suppresses dry eye signs by stimulating tear secretion
por: Nakamachi, Tomoya, et al.
Publicado: (2016)

Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review
por: Atallah, Richard Teofilo, et al.
Publicado: (2019)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
por: Ng, Alison, et al.
Publicado: (2018)

Response to: Comment on “The Effects of Hemodialysis on Tear Osmolarity”
por: Taskapili, Muhittin, et al.
Publicado: (2016)

Comparative Assessment of Tear Function Tests, Tear Osmolarity, and Conjunctival Impression Cytology between Patients with Pterygium and Healthy Eyes
por: Safarzadeh, Masoud, et al.
Publicado: (2019)

Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease
por: Nichols, Kelly K, et al.
Publicado: (2018)

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease
por: McMullin, David, et al.
Publicado: (2021)

Lifitegrast Ophthalmic Solution 5% Is a Safe and Efficient Eyedrop for Dry Eye Disease: A Systematic Review and Meta-Analysis
por: Li, Jing-Xing, et al.
Publicado: (2022)

Association between dry eye symptoms and signs
por: Kyei, Samuel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_push0ee5j597e713kvse1nm0i8